HOME › DRUGS › ALISKIREN;HYDROCHLOROTHIAZIDE
ACTIVE SUBSTANCE / INN

ALISKIREN;HYDROCHLOROTHIAZIDE

Brand name(s): Rasilez HCT, Riprazo HCT, Sprimeo HCT
EMA LISTED
WITHDRAWN
Hypertension
ACTIVE SUBSTANCE
Aliskiren;Hydrochlorothiazide
REGULATORS
EMA
SPONSORS / MAH
Novartis Europharm Ltd., Noden Pharma DAC
TOTAL APPLICATIONS
3
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Rasilez HCTNoden Pharma DACWithdrawn16/01/2009Hypertension
Riprazo HCTNovartis Europharm Ltd.Withdrawn13/04/2011Hypertension
Sprimeo HCTNovartis Europharm Ltd.Withdrawn23/06/2011Hypertension

FULL INTELLIGENCE ON ALISKIREN;HYDROCHLOROTHIAZIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →